Clinical Trial Update: Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the immunogenicity and safety of the MeMuRu-OKA measles-mumps-rubella-varicella vaccine compared with Priorix given with Varilrix; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• MeMuRu-OKA
• Priorix (Measles-Mumps-Rubella Vaccine)
• Varilrix (varicella vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Varicella, Rubella | Phase 2 | Status: COMPLETED